Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.

Status:	Active, not recruiting
Conditions:	Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	10/7/2018
Start Date:	May 2016
End Date:	May 2019

Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy

Electronic activity monitoring (EAM) devices are wearable electronic devices that monitor
functional activity and provide personal feedback on activity progression. This study aims to
determine if EAM can provide an objective, assessment of patient functional activity. The
study will also examine the change in functional activity experienced by patients during the
first cycle of chemotherapy. Another objective of the study will be to see if baseline
functional activity and the change in functional activity that occurs during the first cycle
of chemotherapy can be used to predict patient tolerability of subsequent cycles of
chemotherapy.

Inclusion Criteria:

- Clinical diagnosis of gastrointestinal malignancy.

- Age ≥ 18 years

- Planned to receive systemic chemotherapy, either adjuvant chemotherapy, or neoadjuvant
chemotherapy, or any new line of chemotherapy in the setting of advanced disease.
Subjects may enroll prior to chemotherapy or during the first cycle of treatment.

Exclusion Criteria:

- Restricted mobility defined as dependence or anytime use of a walker or wheelchair in
the past three months.

- Refusing systemic chemotherapy.

- Concurrent radiotherapy with chemotherapy

- Have received at least one cycle of chemotherapy in the current chemotherapy regimen.

We found this trial at

sites

Memorial Sloan Kettering Commack

Commack, New York 11725

Phone: 646-888-3651

from

Commack, NY